Clinical Trial Update: Experimental Autologous Mesenchymal Stem Cell Therapy in Treatment of Chronic Autoimmune Urticaria [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating autologous mesenchymal stem cell therapy for chronic autoimmune urticaria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Diseases
• Autoimmune Urticaria

Drugs mentioned

• Experimental Autologous Mesenchymal Stem Cell Therapy (autologous mesenchymal stem cells)

Snippet

Sponsor: Celal Bayar University | Conditions: Urticaria, Autoimmune Diseases | EARLY_Phase 1 | Status: COMPLETED